It seems every week the SGLT-2 inhibitors are in the news, one time good and one time bad. Now there is a new study that shows that these products may have the ability to protect the kidneys in patients with type 2 diabetes. Since we have had so many articles …

New data from the EMPA-REG-OUTCOME study provide more evidence of the renoprotective effects of empagliflozin in patients with type 2 and cardiovascular disease.

Study finds increased risk during and after pregnancy

Individuals with diabetes who experience hypoglycemia at increased risk for developing cognitive dysfunction and dementia.

Study focuses on quality and quantity of carb consumption during pregnancy.

Fasting found to lead to deterioration of glycemic control in people with type 2 diabetes.

All the following are true about smoking and heart disease EXCEPT: A. Compared with nonsmokers, the incidence of myocardial infarction (MI) is increased 6-fold in women who smoke approximately 20 cigarettes per day. B. Male smokers are 25% more likely to develop coronary heart disease than female smokers. C. Smoking cessation rapidly increases high-density lipoprotein (HDL) cholesterol. D. Smokers who take a thrombolytic agent for an acute MI have better outcomes than nonsmokers. E. All of these statements are true. Do you have the right answer? Follow the link to see.

Do you agree with the statement: Doing a monthly A1c test could act as a way to motivate patients to better care? Follow the link to share your response and see what your colleagues think!

Dr. George Bakris, MD, is a referral nephrologist, board-certified hypertension specialist, and professor of medicine and director of ASH Comprehensive Hypertension Center at The University of Chicago. He specializes in kidney disease as it relates to diabetes and blood pressure issues. In this interview, Dr. Bakris shares his excitement for the results of some important diabetes trials.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about kidney disease, cardiovascular disease, and their relationship to diabetes.